The Main Structural Types of Inhibitors of Matrix Metalloproteinases
- Authors: Kapranov L.E.1, Reznikov A.N.1, Klimochkin Y.N.1
- 
							Affiliations: 
							- Samara State Technical University
 
- Issue: Vol 51, No 3 (2017)
- Pages: 175-181
- Section: Search for New Drugs
- URL: https://ogarev-online.ru/0091-150X/article/view/244524
- DOI: https://doi.org/10.1007/s11094-017-1577-4
- ID: 244524
Cite item
Abstract
This review addresses the main structural types of matrix metalloproteinase (MMP) inhibitors - hydroxamic acid derivatives, sulfonamides, bisphosphonates, compounds combining phosphoryl and hydroxamate groups, and functional derivatives of phosphonic and phosphinic acids. The selectivity of the inhibitory actions of these substances in relation to different types of MMP and the potential for the practical application of these substances in cancer treatment are discussed.
About the authors
L. E. Kapranov
Samara State Technical University
														Email: orgphosphorus@yandex.ru
				                					                																			                												                	Russian Federation, 							244 Molodogvardeiskaya Street, Samara, 443100						
A. N. Reznikov
Samara State Technical University
							Author for correspondence.
							Email: orgphosphorus@yandex.ru
				                					                																			                												                	Russian Federation, 							244 Molodogvardeiskaya Street, Samara, 443100						
Yu. N. Klimochkin
Samara State Technical University
														Email: orgphosphorus@yandex.ru
				                					                																			                												                	Russian Federation, 							244 Molodogvardeiskaya Street, Samara, 443100						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					